Evidence map›Paper›PMID 34631925›Full record

ArticleOpen forum infectious diseases2021

Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts.

Anne K Monroe, Matthew E Levy, Alan E Greenberg, Jeanne C Keruly, Richard D Moore, Michael A Horberg, Paige Kulie, Bernadine S Mohanraj, Princy N Kumar, Amanda D Castel and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Prevention, treatment and cure of HIV infection.Nature reviews. Microbiology · 2023
    Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Anne K MonroeThe George Washington University, Washington, DC, USA.ORCID https://orcid.org/0000-0003-3201-3845
Matthew E LevyWestat, Rockville, Maryland, USA.
Alan E GreenbergThe George Washington University, Washington, DC, USA.
Jeanne C KerulyThe Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Richard D MooreThe Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Michael A HorbergKaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
Paige KulieThe George Washington University, Washington, DC, USA.
Bernadine S MohanrajGeorgetown University School of Medicine, Washington, DC, USA.
Princy N KumarGeorgetown University School of Medicine, Washington, DC, USA.
Amanda D CastelThe George Washington University, Washington, DC, USA.
DC Cohort Executive Committee
George Washington University · USKaiser Permanente · USGeorgetown University · USJohns Hopkins University · USWestat (United States) · US

Funding

The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DCR24AI152598 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Amanda Derryck Castel, Marinella Temprosa · 2020 to 2026
$37.9M
NIAID NIH HHS R24 AI152598
6 · The paper itself

Abstract

Integrase inhibitors (INSTIs) are recommended by expert panels as initial therapy for people with HIV. Because there can be disparities in prescribing and uptake of novel and/or recommended therapies, this analysis assessed potential INSTI prescribing disparities using a combined data set from the Johns Hopkins HIV Clinical Cohort and the DC Cohort. We performed multivariable logistic regression to identify factors associated with ever being prescribed an INSTI. Disparities were noted, including clinic location, age, and being transgender. Identifying disparities may allow clinicians to focus their attention on these individuals and ensure that therapy decisions are grounded in valid clinical reasons.

Indexed as

cohortdisparitiesHIVintegrase strand transfer inhibitors (INSTIs)transgender

Identifiers

PMID34631925
PMCPMC8496514
OpenAlexW3186740455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.